Retrospective Study on the Use of Biologicals in Monotherapy in Rheumatoid Arthritis
Phase of Trial: Phase IV
Latest Information Update: 03 Dec 2013
At a glance
- Drugs Tocilizumab (Primary) ; Monoclonal antibodies; Tumour necrosis factor alpha inhibitors
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 30 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jun 2013 Planned End Date changed from 1 Dec 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.